Although NKp44+ ILC3s are not normally found in the peripheral blood of healthy individuals, they were identified in the peripheral blood of AML patients receiving induction chemotherapy and patients who went on to receive alloHSCT. This evidence concerns the gene NCR2 and acute myeloid leukemia.